These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22024754)

  • 1. Evolution of the "autophagamiR".
    Gundara JS; Robinson BG; Sidhu SB
    Autophagy; 2011 Dec; 7(12):1553-4. PubMed ID: 22024754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA profiling of sporadic and hereditary medullary thyroid cancer identifies predictors of nodal metastasis, prognosis, and potential therapeutic targets.
    Abraham D; Jackson N; Gundara JS; Zhao J; Gill AJ; Delbridge L; Robinson BG; Sidhu SB
    Clin Cancer Res; 2011 Jul; 17(14):4772-81. PubMed ID: 21622722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noncoding RNA blockade of autophagy is therapeutic in medullary thyroid cancer.
    Gundara JS; Zhao J; Gill AJ; Lee JC; Delbridge L; Robinson BG; McLean C; Serpell J; Sidhu SB
    Cancer Med; 2015 Feb; 4(2):174-82. PubMed ID: 25487826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA profiles in familial and sporadic medullary thyroid carcinoma: preliminary relationships with RET status and outcome.
    Mian C; Pennelli G; Fassan M; Balistreri M; Barollo S; Cavedon E; Galuppini F; Pizzi M; Vianello F; Pelizzo MR; Girelli ME; Rugge M; Opocher G
    Thyroid; 2012 Sep; 22(9):890-6. PubMed ID: 22747440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two GEO MicroRNA Expression Profile Based High-Throughput Screen to Identify MicroRNA-31-3p Regulating Growth of Medullary Thyroid Carcinoma Cell by Targeting RASA2.
    Jiang M; Shi X; Zhu H; Wei W; Li J
    Med Sci Monit; 2019 Jul; 25():5170-5180. PubMed ID: 31298226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-375/SEC23A as biomarkers of the in vitro efficacy of vandetanib.
    Lassalle S; Zangari J; Popa A; Ilie M; Hofman V; Long E; Patey M; Tissier F; Belléannée G; Trouette H; Catargi B; Peyrottes I; Sadoul JL; Bordone O; Bonnetaud C; Butori C; Bozec A; Guevara N; Santini J; Hénaoui IS; Lemaire G; Blanck O; Vielh P; Barbry P; Mari B; Brest P; Hofman P
    Oncotarget; 2016 May; 7(21):30461-78. PubMed ID: 27036030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulated miR-9-3p Promotes Cell Growth and Inhibits Apoptosis in Medullary Thyroid Carcinoma by Targeting BLCAP.
    Chen Y; Zhang S; Zhao R; Zhao Q; Zhang T
    Oncol Res; 2017 Sep; 25(8):1215-1222. PubMed ID: 27938505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nodal metastasis microRNA expression correlates with the primary tumour in MTC.
    Gundara JS; Zhao JT; Gill AJ; Clifton-Bligh R; Robinson BG; Delbridge L; Sidhu SB
    ANZ J Surg; 2014 Apr; 84(4):235-9. PubMed ID: 23072640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medullary Thyroid Carcinoma: Recent Advances Including MicroRNA Expression.
    Chu YH; Lloyd RV
    Endocr Pathol; 2016 Dec; 27(4):312-324. PubMed ID: 27539727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-182 promotes cancer invasion by linking RET oncogene activated NF-κB to loss of the HES1/Notch1 regulatory circuit.
    Spitschak A; Meier C; Kowtharapu B; Engelmann D; Pützer BM
    Mol Cancer; 2017 Jan; 16(1):24. PubMed ID: 28122586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An investigation on the expression of miRNAs including miR-144 and miR-34a in plasma samples of RET-positive and RET-negative medullar thyroid carcinoma patients.
    Shabani N; Sheikholeslami S; Paryan M; Zarif Yeganeh M; Tavangar SM; Azizi F; Mohammadi-Yeganeh S; Hedayati M
    J Cell Physiol; 2020 Feb; 235(2):1366-1373. PubMed ID: 31297834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs in Medullary Thyroid Carcinoma: A State of the Art Review of the Regulatory Mechanisms and Future Perspectives.
    Galuppini F; Censi S; Moro M; Carraro S; Sbaraglia M; Iacobone M; Fassan M; Mian C; Pennelli G
    Cells; 2021 Apr; 10(4):. PubMed ID: 33924120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RET Kinase-Regulated MicroRNA-153-3p Improves Therapeutic Efficacy in Medullary Thyroid Carcinoma.
    Joo LJS; Weiss J; Gill AJ; Clifton-Bligh R; Brahmbhatt H; MacDiarmid JA; Gild ML; Robinson BG; Zhao JT; Sidhu SB
    Thyroid; 2019 Jun; 29(6):830-844. PubMed ID: 30929576
    [No Abstract]   [Full Text] [Related]  

  • 14. MicroRNA-21 and long non-coding RNA MALAT1 are overexpressed markers in medullary thyroid carcinoma.
    Chu YH; Hardin H; Schneider DF; Chen H; Lloyd RV
    Exp Mol Pathol; 2017 Oct; 103(2):229-236. PubMed ID: 29107050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exceptionality of Distant Metastasis in Node-Negative Hereditary and Sporadic Medullary Thyroid Cancer: Lessons Learned.
    Machens A; Lorenz K; Weber F; Dralle H
    J Clin Endocrinol Metab; 2021 Jul; 106(8):e2968-e2979. PubMed ID: 33788951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR‑592 acts as an oncogene and promotes medullary thyroid cancer tumorigenesis by targeting cyclin‑dependent kinase 8.
    Liu T; Meng J; Zhang Y
    Mol Med Rep; 2020 Oct; 22(4):3316-3326. PubMed ID: 32945439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The HIV protease inhibitor nelfinavir down-regulates RET signaling and induces apoptosis in medullary thyroid cancer cells.
    Kushchayeva Y; Jensen K; Recupero A; Costello J; Patel A; Klubo-Gwiezdzinska J; Boyle L; Burman K; Vasko V
    J Clin Endocrinol Metab; 2014 May; 99(5):E734-45. PubMed ID: 24483157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and prevalence of sporadic and hereditary MTC in Denmark 1960-2014: a nationwide study.
    Mathiesen JS; Kroustrup JP; Vestergaard P; Stochholm K; Poulsen PL; Rasmussen ÅK; Feldt-Rasmussen U; Schytte S; Londero SC; Pedersen HB; Hahn CH; Djurhuus BD; Bentzen J; Möller S; Gaustadnes M; Rossing M; Nielsen FC; Brixen K; Frederiksen AL; Godballe C;
    Endocr Connect; 2018 Jun; 7(6):829-839. PubMed ID: 29760189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-886-3p regulates cell proliferation and migration, and is dysregulated in familial non-medullary thyroid cancer.
    Xiong Y; Zhang L; Holloway AK; Wu X; Su L; Kebebew E
    PLoS One; 2011; 6(10):e24717. PubMed ID: 21998631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic in medullary thyroid cancer: the role of microRNA in tumorigenesis and prognosis.
    Manso J; Censi S; Mian C
    Curr Opin Oncol; 2021 Jan; 33(1):9-15. PubMed ID: 33093335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.